Method for synthesizing medicinal midbody phenanthrene compound in sodium acetate environment

A technology of compound and sodium acetate, which is applied in the direction of hydrocarbons, hydrocarbons, carbon compound catalysts, etc., can solve the problems of insufficient utilization of raw materials, low production efficiency, and inability to meet production needs, etc., and achieve broad industrial application prospects and high production rate effect

Inactive Publication Date: 2016-06-08
胡淑婷
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] As mentioned above, although the preparation methods of various types of phenanthrene compounds have been disclosed in the prior art, these methods still cannot meet the production needs in the fields of medicine and chemical synthesis, because of their inherent low production efficiency and insufficient raw materials. Use and many other issues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing medicinal midbody phenanthrene compound in sodium acetate environment
  • Method for synthesizing medicinal midbody phenanthrene compound in sodium acetate environment
  • Method for synthesizing medicinal midbody phenanthrene compound in sodium acetate environment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047]

[0048] Add an appropriate amount of mixed solvent consisting of PEG-400 and 1-allyl-3-methylimidazolium tetrafluoroborate (the volume ratio of the two is 1:0.1) to the reactor, and then replace it twice with nitrogen, so that The reactor is a nitrogen atmosphere; then add 100mmol of the above formula (II) compound 2-bromo-4'-chlorobiphenyl, 200mmol of the above formula (III) compound styrene, by 3mmolPdCl 2 (dppf) and 6 mmol hexafluorophosphate tetraacetonitrile copper composite catalyst, 10 mmol ligand L1 and 200 mmol diisopropylethanolamine, heated to 60 ° C under stirring, and reacted at this temperature for 12 hours.

[0049] After the reaction, add deionized water to the reaction system, fully shake and wash, separate the organic layer, wash with deionized water again, separate the organic layer; concentrate the organic layer under reduced pressure, remove, and put the residue on a silica gel column Chromatography, eluting with a mixed solvent of n-hexanol and...

Embodiment 2

[0052]

[0053] Add an appropriate amount of mixed solvent (the volume ratio of the two is 1:0.2) consisting of PEG-400 and 1-allyl-3-methylimidazolium tetrafluoroborate to the reactor, and then replace it twice with nitrogen, so that The reactor is a nitrogen atmosphere; then add 100mmol of the formula (II) compound 2-bromobiphenyl, 300mmol of the formula (III) compound 1-methyl-3-vinylbenzene, by 3mmolPdCl 2 (dppf) and 9 mmol hexafluorophosphate tetraacetonitrile copper composite catalyst, 15 mmol ligand L1 and 250 mmol diisopropylethanolamine, heated to 70 ° C under stirring, and reacted at this temperature for 10 hours.

[0054] After the reaction, add deionized water to the reaction system, fully shake and wash, separate the organic layer, wash with deionized water again, separate the organic layer; concentrate the organic layer under reduced pressure, remove, and put the residue on a silica gel column Chromatography, eluting with a mixed solvent of n-hexanol and chlor...

Embodiment 3

[0057]

[0058] Add an appropriate amount of mixed solvent (the volume ratio of the two is 1:0.3) consisting of PEG-400 and 1-allyl-3-methylimidazolium tetrafluoroborate to the reactor, and then replace it twice with nitrogen, so that The reactor is a nitrogen atmosphere; then add 100mmol of the formula (II) compound 2-bromobiphenyl, 400mmol of the formula (III) compound 1-vinylnaphthalene, by 3mmolPdCl 2 (dppf) and 12 mmol hexafluorophosphate tetraacetonitrile copper composite catalyst, 20 mmol ligand L1 and 300 mmol diisopropylethanolamine, heated to 80 ° C under stirring, and reacted at this temperature for 8 hours.

[0059] After the reaction, add deionized water to the reaction system, fully shake and wash, separate the organic layer, wash with deionized water again, separate the organic layer; concentrate the organic layer under reduced pressure, remove, and put the residue on a silica gel column Chromatography, the mixed solvent of n-hexanol and chloroform with a vol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for synthesizing a medicinal midbody phenanthrene compound of the formula (I) as shown in the description in a sodium acetate environment. The method comprises the following step: in the presence of a catalyst, organic ligand and sodium acetate in an inert atmosphere, enabling a compound of the formula (II) and a compound of the formula (III) as shown in the description to react in a solvent, thereby obtaining the compound of the formula (I), wherein R1 and R2 are independently H, C1-C6 alkyl, C1-C6 alkoxy or halogen; R3 is C6-C10 aryl or C5-C8 ceteroary; C6-C10 aryl or C4-C8 ceteroary is randomly substituted by 1-3 substituent groups; the substituent group is C1-C6 alkyl or halogen. Due to selection of the appropriate catalyst, organic ligand, alkali and solvent, a good effect is achieved, and the method is wide in industrial application prospect.

Description

[0001] The application of the present invention is a divisional application of the application number 201510100568.5 (a method for synthesizing pharmaceutical intermediate phenanthrene compounds) filed on March 6, 2015. technical field [0002] The invention relates to a method for synthesizing condensed ring compounds, more specifically to a method for synthesizing a pharmaceutical intermediate phenanthrene compound, and belongs to the fields of organic synthesis and pharmaceutical intermediate synthesis. Background technique [0003] Fused ring compounds such as naphthalene, anthracene, phenanthrene and other compounds have attracted the attention and attention of pharmaceutical researchers due to their ubiquitous biological activities. Among them, phenanthrene and its derivatives are an important class of aromatic compounds, which have been widely used in the fields of drug design and synthesis, and material research and development. [0004] It is precisely because of su...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07B37/10C07C25/22C07C17/266C07C15/30C07C2/42C07D213/127C07D213/16
CPCC07B37/10C07C2/42C07C17/266C07C2531/22C07D213/127C07D213/16C07C25/22C07C15/30
Inventor 翟学研
Owner 胡淑婷
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap